Clinical Trials
9
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)β’ Click on a phase to view related trials
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
- Conditions
- Trigeminal Neuralgia
- Interventions
- First Posted Date
- 2015-06-16
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- Capnia, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02473016
- Locations
- πΊπΈ
University of California, Los Angeles (UCLA), Los Angeles, California, United States
πΊπΈMeridien Research, Tampa, Florida, United States
πΊπΈColumbia University Medical Center, New York, New York, United States
The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine
- First Posted Date
- 2010-12-06
- Last Posted Date
- 2013-10-31
- Lead Sponsor
- Capnia, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT01253915
- Locations
- πΊπΈ
Naval Medical Center San Diego - Dept of Neurology, San Diego, California, United States
πΊπΈWalter Reed National Military Medical Center - Dept of Neurology, Bethesda, Maryland, United States
πΊπΈNaval Medical Center Portsmouth - Dept of Neurology, Portsmouth, Virginia, United States
The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Nasal CO2Drug: Inactive Placebo Gas
- First Posted Date
- 2009-06-10
- Last Posted Date
- 2012-08-15
- Lead Sponsor
- Capnia, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00917020
- Locations
- πΊπΈ
Capnia Investigative Site, St. Louis, Missouri, United States
The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Nasal CO2Drug: Inactive Placebo Gas
- First Posted Date
- 2009-06-10
- Last Posted Date
- 2012-08-15
- Lead Sponsor
- Capnia, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT00917111
- Locations
- πΊπΈ
Capnia Investigative Site, Omaha, Nebraska, United States
The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines
- Conditions
- Migraine
- Interventions
- Drug: Inactive PlaceboDrug: Nasal CO2
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2012-08-15
- Lead Sponsor
- Capnia, Inc.
- Target Recruit Count
- 292
- Registration Number
- NCT00690716
- Locations
- πΊπΈ
Capnia Investigative Site, Seattle, Washington, United States
- Prev
- 1
- 2
- Next